Rosemary Dray-Spira
Overview
Explore the profile of Rosemary Dray-Spira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
2413
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meyer A, Marty L, Drouin J, Weill A, Carbonnel F, Dray-Spira R
Clin Gastroenterol Hepatol
. 2025 Feb;
PMID: 40020958
Background & Aims: Limited data are available on the risk of major congenital malformations (MCM) of thiopurines and anti-TNF during pregnancy. In this study, we assess the risk of MCM...
2.
Tubiana S, Rontani M, Herlemont P, Dray-Spira R, Zureik M, Weill A, et al.
Infect Dis (Lond)
. 2025 Feb;
:1-11.
PMID: 40016873
Context: Increased risks of death and hospitalisation for organ disorders after discharge for COVID-19 hospitalisation have been reported but their persistence is unknown. Methods: We conducted a nationwide cohort study...
3.
Le Vu S, Bertrand M, Semenzato L, Jabagi M, Botton J, Drouin J, et al.
Nat Commun
. 2024 Sep;
15(1):7745.
PMID: 39232036
Myocarditis is the most salient serious adverse event following messenger RNA-based Covid-19 vaccines. The highest risk is observed after the second dose compared to the first, whereas the level of...
4.
Botton J, Bertrand M, Jabagi M, Duranteau L, Bouillon K, Drouin J, et al.
Vaccine
. 2024 Sep;
42(24):126252.
PMID: 39226788
Background: COVID-19 vaccination has been inconsistently associated with an increased risk of heavy menstrual bleeding in previous studies. This study aimed to assess the risk of heavy menstrual bleeding requiring...
5.
Semenzato L, Le Vu S, Botton J, Bertrand M, Jabagi M, Drouin J, et al.
JAMA
. 2024 Aug;
PMID: 39186694
Importance: Although patients with myocarditis after COVID-19 mRNA vaccination appear to have a good prognosis near hospital discharge, their longer-term prognosis and management remain unknown. Objective: To study the cardiovascular...
6.
Blangis F, Drouin J, Launay E, Miranda S, Zureik M, Cohen J, et al.
Lancet Reg Health Eur
. 2024 Jul;
42:100921.
PMID: 39070743
Background: Identifying risk factors for early child physical abuse (CPA) is crucial for understanding its mechanisms and defining effective preventive interventions. We aimed to identify maternal, prenatal and postnatal factors...
7.
Turpin A, Semenzato L, Le Vu S, Jabagi M, Bouillon K, Drouin J, et al.
J Infect Public Health
. 2024 Jun;
17(7):102450.
PMID: 38823086
Background: In spite of major effectiveness, a residual risk after COVID-19 primary vaccination was identified, in particular, for vulnerable individuals of advanced age or with comorbidities. Less is known about...
8.
Hoisnard L, Meyer A, Dray-Spira R, Weill A, Zureik M, Sbidian E
Arthritis Rheumatol
. 2024 May;
76(9):1364-1376.
PMID: 38699822
Objective: To compare the risk of gastrointestinal perforation (GIP), a rare but serious adverse event, in patients who a JAK inhibitor (JAKi; tofacitinib, baricitinib, upadacitinib, or filgotinib) versus adalimumab (tumor...
9.
Rios P, Herlemont P, Fauque P, Lacour B, Jouannet P, Weill A, et al.
JAMA Netw Open
. 2024 May;
7(5):e249429.
PMID: 38696167
Importance: Cancer is a leading cause of death among children worldwide. Treatments used for medically assisted reproduction (MAR) are suspected risk factors because of their potential for epigenetic disturbance and...
10.
Swital M, Drouin J, Miranda S, Bakchine S, Botton J, Dray-Spira R
Mult Scler
. 2024 Jan;
30(2):227-237.
PMID: 38281078
Background: Multiple sclerosis (MS) frequently affects women of childbearing age and pregnant women. Objective: To assess the use of MS disease-modifying therapies (DMTs) during pregnancy in France over the last...